Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Aug;103(4):1893–1898. doi: 10.1111/j.1476-5381.1991.tb12348.x

The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.

A L Chamienia 1, E J Johns 1
PMCID: PMC1908187  PMID: 1833019

Abstract

1. The present study was designed to determine how the natriuretic and diuretic actions of atrial natriuretic peptides were modulated by circulating angiotensin II. 2. In sodium pentobarbitone-anaesthetized rats, administration of bolus doses of atriopeptin III (1000 ng kg-1) had no effect on blood pressure, renal blood flow, or glomerular filtration rate but caused reversible increases (all P less than 0.001) in urine flow, of 53.9 +/- 14.4 microliters kg-1 min-1, absolute sodium excretion, of 13.4 +/- 2.9 mumol kg-1 min-1 and fractional sodium excretion of 3.26 +/- 0.74%. Similar effects were seen following a second dose of the atriopeptin III. 3. Following blockade of the renin-angiotensin system with captopril (900 micrograms kg-1 h-1), control levels of blood pressure and haemodynamics were unchanged but there were significant (all P less than 0.001) increases in urine flow, from 39.96 +/- 5.05 to 88.70 +/- 8.41 microliters kg-1 min-1, absolute sodium excretion, from 8.35 +/- 1.08 to 21.62 +/- 1.62 mumol kg-1 min-1 and fractional sodium excretion, from 3.82 +/- 0.23 to 5.34 +/- 0.32%. Under these conditions, atriopeptin III-induced increases in urine flow (110.2 +/- 8.7 versus 43.9 +/- 6.2 microliters kg-1 min-1) absolute (24.0 +/- 1.8 versus 9.3 +/- 1.2 mumol kg-1 min-1) and fractional (5.16 +/- 0.24 versus 2.08 +/- 0.33%) sodium excretions were significantly (P less than 0.001) greater.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1894

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOJESEN E. A method for determination of inulin in plasma and urine. Acta Med Scand Suppl. 1952;266:275–282. doi: 10.1111/j.0954-6820.1952.tb13376.x. [DOI] [PubMed] [Google Scholar]
  2. Brenner B. M., Ballermann B. J., Gunning M. E., Zeidel M. L. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 1990 Jul;70(3):665–699. doi: 10.1152/physrev.1990.70.3.665. [DOI] [PubMed] [Google Scholar]
  3. Gaillard C. A., Koomans H. A., Mees E. J. Enalapril attenuates natriuresis of atrial natriuretic factor in humans. Hypertension. 1988 Feb;11(2):160–165. doi: 10.1161/01.hyp.11.2.160. [DOI] [PubMed] [Google Scholar]
  4. Harris P. J., Skinner S. L. Intra-renal interactions between angiotensin II and atrial natriuretic factor. Kidney Int Suppl. 1990 Nov;30:S87–S91. [PubMed] [Google Scholar]
  5. Healy D. P., Fanestil D. D. Localization of atrial natriuretic peptide binding sites within the rat kidney. Am J Physiol. 1986 Mar;250(3 Pt 2):F573–F578. doi: 10.1152/ajprenal.1986.250.3.F573. [DOI] [PubMed] [Google Scholar]
  6. Johns E. J. Role of angiotensin II and the sympathetic nervous system in the control of renal function. J Hypertens. 1989 Sep;7(9):695–701. [PubMed] [Google Scholar]
  7. Johns E. J., Rutkowski B. A comparison of the action of atriopeptin III on renal function in normal and DOCA-salt hypertensive rats. J Hypertens. 1989 Aug;7(8):675–682. doi: 10.1097/00004872-198908000-00012. [DOI] [PubMed] [Google Scholar]
  8. Johns E. J., Rutkowski B. Renal actions of atriopeptin III in genetic and renovascular models of hypertension in the rat. Eur J Pharmacol. 1990 Aug 28;185(2-3):125–135. doi: 10.1016/0014-2999(90)90632-g. [DOI] [PubMed] [Google Scholar]
  9. Johns E. J., Rutkowski B. The action of atriopeptin III on renal function in two models of chronic renal failure in the rat. Br J Pharmacol. 1990 Feb;99(2):317–322. doi: 10.1111/j.1476-5381.1990.tb14701.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Koepke J. P., Jones S., DiBona G. F. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol. 1987 May;252(5 Pt 2):R1019–R1023. doi: 10.1152/ajpregu.1987.252.5.R1019. [DOI] [PubMed] [Google Scholar]
  11. Koseki C., Hayashi Y., Torikai S., Furuya M., Ohnuma N., Imai M. Localization of binding sites for alpha-rat atrial natriuretic polypeptide in rat kidney. Am J Physiol. 1986 Feb;250(2 Pt 2):F210–F216. doi: 10.1152/ajprenal.1986.250.2.F210. [DOI] [PubMed] [Google Scholar]
  12. Luft F. C., Lang R. E., Aronoff G. R., Ruskoaho H., Toth M., Ganten D., Sterzel R. B., Unger T. Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. J Pharmacol Exp Ther. 1986 Feb;236(2):416–418. [PubMed] [Google Scholar]
  13. Needleman P., Blaine E. H., Greenwald J. E., Michener M. L., Saper C. B., Stockmann P. T., Tolunay H. E. The biochemical pharmacology of atrial peptides. Annu Rev Pharmacol Toxicol. 1989;29:23–54. doi: 10.1146/annurev.pa.29.040189.000323. [DOI] [PubMed] [Google Scholar]
  14. Salazar F. J., Granger J. P., Fiksen-Olsen M. J., Bentley M. D., Romero J. C. Possible modulatory role of angiotensin II on atrial peptide-induced natriuresis. Am J Physiol. 1987 Nov;253(5 Pt 2):F880–F883. doi: 10.1152/ajprenal.1987.253.5.F880. [DOI] [PubMed] [Google Scholar]
  15. Showalter C. J., Zimmerman R. S., Schwab T. R., Edwards B. S., Opgenorth T. J., Burnett J. C., Jr Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol. 1988 Mar;254(3 Pt 2):R453–R456. doi: 10.1152/ajpregu.1988.254.3.R453. [DOI] [PubMed] [Google Scholar]
  16. Sonnenberg H., Honrath U., Chong C. K., Wilson D. R. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol. 1986 Jun;250(6 Pt 2):F963–F966. doi: 10.1152/ajprenal.1986.250.6.F963. [DOI] [PubMed] [Google Scholar]
  17. Steele T. H., Challoner-Hue L. Intrarenal angiotensin II inhibition influences the actions of atrial natriuretic peptide. Clin Sci (Lond) 1990 May;78(5):475–480. doi: 10.1042/cs0780475. [DOI] [PubMed] [Google Scholar]
  18. Wambach G., Schittenhelm U., Stimpel M., Bönner G., Kaufmann W. Natriuretic action of ANP is blunted by ACE inhibition in humans. J Cardiovasc Pharmacol. 1989 May;13(5):748–753. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES